| Name | Relationship | Address | Signature | Signature date | CIK |
|---|---|---|---|---|---|
| McGowan Mark | Director | C/O ENOVA INTERNATIONAL, INC., 175 W. JACKSON BOULEVARD, SUITE 600, CHICAGO | Sean Rahilly, attorney in fact | 16 May 2025 | 0001482192 |
| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | ENVA | Common stock, par value $0.00001 per share | Award | $0 | +1.8K | +4.11% | $0.00 | 45.7K | 14 May 2025 | Direct | F1 |
| holding | ENVA | Common stock, par value $0.00001 per share | 21.6K | 14 May 2025 | By SAF Capital Fund | F2 |
| Id | Content |
|---|---|
| F1 | Reflects a grant of Restricted Stock Units ("RSUs"), 100% of which shall vest on May 14, 2026, as long as grantee serves as a member of the board of directors of Enova International, Inc. ("Issuer") as of such date. |
| F2 | The reporting person disclaims beneficial ownership of the securities held through SAF Capital Fund except to the extent of his pecuniary interest therein, and this report shall not be deemed an admission that the reporting person is the beneficial owner of the securities for purposes of Section 16. |